Market Overview

Benchmark Initiates Applied DNA Sciences With Speculative Buy


Analysts at Benchmark initiated coverage on Applied DNA Sciences Inc (NASDAQ: APDN) with a Speculative Buy rating.

The target price for Applied DNA Sciences is set to $5.

Applied DNA Sciences shares have dropped 61.36 percent over the past 52 weeks, while the S&P 500 index has surged 11.87 percent in the same period.

Applied DNA Sciences' shares rose 2.41 percent to close at $2.55 on Friday.

Latest Ratings for APDN

Jul 2020HC Wainwright & Co.MaintainsBuy
Jul 2020HC Wainwright & Co.Initiates Coverage OnBuy
Nov 2019Maxim GroupUpgradesHoldBuy

View More Analyst Ratings for APDN
View the Latest Analyst Ratings


Related Articles (APDN)

View Comments and Join the Discussion!

Posted-In: BenchmarkInitiation Analyst Ratings

Latest Ratings

DEMorgan StanleyMaintains335.0
SBNYRaymond JamesMaintains138.0
CORTHC Wainwright & Co.Maintains32.0
AHEXYMorgan StanleyDowngrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at